PFD decreases the expression of profibrotic factors such as transforming growth factor-β1 (TGF-β1) and inflammatory cytokines, such as tumor necrosis factor-α, interleukin (IL)-1β, and IL-13 [4,5]. This evidence concerns the gene TGFB1 and polyostotic fibrous dysplasia.